Actualités sur Forschung

Suivre
Abonner Forschung
Filtre
  • 29.11.2022 – 22:46

    News Direct

    VectorBuilderille merkittävän innovaatiokilpailun ensimmäinen palkinto

    Chicago, IL (ots) - --News Direct-- Maailman johtaviin geeninsiirtoteknologiayhtiöihin lukeutuva VectorBuilder Inc. kertoo Guangzhoussa sijaitsevan tuotekehitys- ja valmistuskeskuksensa voittaneen 7. Kiinan Hangzhoussa järjestetyn Chuangke Innovation and Entrepreneurship Global Competition -innovaatiokilpailun. Tämä arvostettu ja korkeatasoinen kilpailu on Kiinan ...

  • 29.11.2022 – 13:32

    News Direct

    VectorBuilder vann första pris i stor innovationstävling

    Chicago, IL (ots) - --News Direct-- VectorBuilder Inc. - en global ledare inom genleveransteknik - meddelade att deras FoU- och tillverkningscenter i Guangzhou vann mästerskapet i sjunde globala tävlingen i innovation och företagande, som hölls i "Chuangke" Hangzhou, Kina. Denna inflytelserika och mycket konkurrensdrivna tävling är en av de största i Kina och täcker företag i tillväxtstadiet inom alla ...

  • 12.07.2022 – 14:00

    Firmenich

    Firmenich appoints Dr Eric Frérot as Distinguished Scientist

    Geneva (ots/PRNewswire) - Firmenich, the world's largest privately-owned fragrance and taste company, is proud to announce the appointment of Dr Eric Frérot as Distinguished Scientist. This nomination acknowledges his successful track-record within R&D, his instrumental role in breakthrough innovations, and his consistent exceptional performance in the field of science. He is one of only seven scientists inside the ...

  • 30.06.2022 – 13:01

    Neuromod Devices Ltd

    Neuromod Publishes Results of Second Large Scale Clinical Trial for Tinnitus in Top-Tier Scientific Journal, Shows Greater Improvement of Symptoms

    Dublin (ots/PRNewswire) - - Second large-scale trial shows greater reduction in tinnitus symptom severity using bimodal neuromodulation device, Lenire® - 91% of treatment compliant participants experienced improvement in tinnitus symptoms that sustained 12 months after treatment - 87.8% said they would recommend ...

  • 28.03.2022 – 13:35

    Abcam plc

    Abcam the most awarded company at 2022 industry awards

    Cambridge, England (ots/PRNewswire) - CAMBRIDGE, England, March 25, 2022 Abcam (AIM:ABC); (NASDAQ:ABCM), today announced that it has received six recognitions from CiteAb at their annual industry awards, the highest of any participant evaluated this year. This record number of acknowledgments follows a year of substantial investment for Abcam to enable life sciences researchers from academia and industry to advance ...

  • 25.03.2022 – 14:22

    Abcam

    Abcam the most awarded company at 2022 industry awards

    Cambridge, England (ots/PRNewswire) - CAMBRIDGE, England, March 25, 2022 Abcam (AIM:ABC); (NASDAQ:ABCM), today announced that it has received six recognitions from CiteAb at their annual industry awards, the highest of any participant evaluated this year. This record number of acknowledgments follows a year of substantial investment for Abcam to enable life sciences researchers from academia and industry to advance ...

  • 03.11.2021 – 09:01

    Zentiva

    Zentiva Advances Pharmaceutical Research Through ORBIS Project

    Prague (ots/PRNewswire) - One of the missions that Zentiva has consistently pursued is to connect Academia and the Pharmaceutical Industry to accelerate drug development innovation and meet the unmet needs of the patients. Our company is pleased to resume the scientific exchange program as part of the ORBIS project, which was created within the largest EU grant programs HORIZON 2020, to connect European and American ...

  • 14.10.2021 – 14:00

    Schweizerischer Nationalfonds / Fonds national suisse

    SNSF opposes initiative to ban animal and human experimentation

    Bern, 14.10.2021 (ots) - The Swiss National Science Foundation (SNSF) strives consistently and continuously to improve the quality of research. A ban on animal and human experiments would massively restrict the opportunity to gain knowledge and adversely affect Switzerland as a research hub. On 13 February 2022, the Swiss electorate will vote on the initiative to ban animal and human experiments. Acceptance of the ...

  • 13.07.2021 – 13:00

    Abcam plc

    Abcam opens new US facility in Boston, MA

    Cambridge (ots/PRNewswire) - Supporting accelerated growth of R&D, manufacturing, and commercial activities with new 100,000 sq-ft state-of-the-art facility Reinforcing commitment to the region as Abcam approaches 20 years of US presence Abcam (AIM: ABC) (NASDAQ: ABCM), a global innovator in life sciences reagents and tools, today announces the opening of a major new site in Waltham, MA. The new facility is a central ...

  • 13.07.2021 – 08:00

    Schweizerischer Nationalfonds / Fonds national suisse

    Clinical research: patients and the public have their say

    Bern (ots) - The Swiss National Science Foundation has been funding clinical studies on under-researched topics in medicine since 2016. In a first, it successfully involved representatives of patients and the public in evaluating applications. The aim of the SNSF's Investigator Initiated Clinical Trials (IICT) programme is to answer medical questions that are important to society but not a priority for industry. This ...

  • 07.06.2021 – 11:00

    Fundação Bial

    BIAL Award in Biomedicine worth 300,000 Euros, nominations until 30 June

    Porto, Portugal (ots/PRNewswire) - The second edition of the BIAL Award in Biomedicine is currently underway. Worth three hundred thousand Euros, this prize is intended to reward a work with exceptional quality results and scientific relevance published in the last ten years in the broad field of biomedicine. The winner will be chosen by an independent and ...

  • 28.04.2021 – 16:48

    CAS

    CAS launches new brand reflecting strategic evolution to empower smarter science

    Columbus, Ohio (ots/PRNewswire) - Expanding portfolio of solutions and capabilities addressing growing need for curated scientific data and expertise to accelerate discovery CAS, a division of the American Chemical Society (ACS) that specializes in scientific information solutions, today launched a new brand reflecting the broadening scope of its solutions and ...

  • 08.03.2021 – 11:00

    Schweizerischer Nationalfonds / Fonds national suisse

    The Swiss National Science Foundation and Innosuisse to step up cooperation

    Bern (ots) - The implementation of research results is of central importance for the economy and society. The SNSF and Innosuisse have signed an agreement to further strengthen the interaction between science and innovation. Through this agreement, the SNSF and Innosuisse are reiterating their shared understanding of the fact that the innovation chain - from basic ...

  • 08.03.2021 – 08:01

    Novogene Europe

    Novogene Europe Launches Clinical Sequencing Services for its European Customers

    Cambridge, England (ots/PRNewswire) - Novogene Europe, a leading provider of genomic services and solutions, has announced the launch of a Clinical Service to provide its European customers with next-generation sequencing (NGS) services and solutions for their clinical samples. The Clinical Service has launched after Novogene's Cambridge Sequencing Centre was awarded ...

  • 23.02.2021 – 07:00

    UCB Pharma

    UCB and Microsoft Expand Collaboration to Accelerate Drug Discovery and Development

    Brussels and Atlanta (ots/PRNewswire) - - Through this collaboration with Microsoft, UCB seeks to discover and develop medicines faster for people living with severe diseases in immunology and neurology - Microsoft will provide AI technology and applied scientists to work alongside UCB's scientists and data specialists, aiming to allow UCB to discover new correlations ...

  • 08.12.2020 – 13:00

    Abcam plc

    Abcam reveals new cell engineering facility in Bay Area

    Cambridge, England (ots/PRNewswire) - - State-of-the-art site will enable rapid delivery of engineered cell lines - Powering ready-to-use edited cell-line portfolio expansion - Enable comprehensive customization for research, diagnostic and therapeutic development Today Abcam (AIM:ABC; NASDAQ:ABCM), a global innovator in life science reagents and tools, announced the opening of a new 16,000 sq ft purpose-fitted facility ...